Our aim is to continue to grow and expand our competitive position. Our own research forms an important pillar of our growth strategy, but so too does our collaboration with strong partners. Our most important concern is and will always be to provide patients with rapid access to innovative medicines.
That is why we are always on the lookout for new partnerships and cooperation opportunities.
We are particularly interested in products and technologies that offer patients a proven additional therapeutic benefit compared to existing therapies.
Our partnerships extend not only to straightforward purchase and sale of products, but also to licence rights (in-licensing and out-licensing) as well as co-marketing and co-promotion. The size of the company does not matter to us – we work with small manufacturers of niche products as well as with global players.
